Concepedia

Mohamed Saad

MS

Statistics

Publications

19

Citations

1.6K

H-Index

14

Active since

2017

Affiliations

Hamad Medical Corporation(Current)

Hamad General Hospital

Qatar University

Weill Cornell Medical College in Qatar

University of Oxford

Mohamed Saad is an author at Hamad Medical Corporation specializing in pharmacy, pharmacotherapy, and medicine.

ORCID

Publications per year

2017–2025

19

Publications

19

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

, , +6

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

, , +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

, , +13

Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis

Authia P Gray, Erin Chung, Rebecca Hsu et al. · The Lancet Global Health · 2025 · 103 citations · Full text

, , +17

Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial

Fatima Khalifa Al‐Sulaiti, Ahmed Nader, Mohamed Saad et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2019 · 46 citations · Full text

, , +13

1–5 of 19